Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety
NCT ID: NCT07259005
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
96 participants
INTERVENTIONAL
2025-04-10
2028-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In response to the demand for improved treatments for SA, this project aims to explore the efficacy of a novel treatment approach integrating online psychotherapy with online breathwork sessions designed to induce ASC.
We will recruit 96 individuals with SA, who will be randomly divided into two groups: one group will receive the new combined breathwork-assisted psychotherapy, and the other an active control intervention that does not induce ASC. Over the treatment duration, the effectiveness of these treatments will be closely monitored using established psychological scales and by observing patients in live interactions before and after therapy.
This project is expected to open the way to a more accessible and effective treatment option for a large group of people struggling with SA. More broadly, the findings will also contribute to our understanding of how ASC, induced through breathing techniques, can be used therapeutically. This could change the way a variety of mental health conditions (e.g., other anxiety-related conditions and depression) are treated, making a substantial impact on public health and the way mental health disorders are approached and managed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Coherent Breathing Breathwork on Health
NCT05676658
Online Program for Social Anxiety
NCT02792127
Does Conscious Connected Breathwork Reduce Symptoms of Anxiety?
NCT06374810
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
NCT05117255
Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder
NCT02592564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: The aim is to test online-delivered breathwork-assisted therapy to reduce social anxiety.
Study design: The study will be conducted according to a randomized, experimental, between-groups design with two breathwork-assisted therapy interventions. The intervention will consist of a total of 6 sessions including two preparation sessions, two breathwork sessions, and two integration session.
Study population: 96 adult individuals with social anxiety (Liebowitz Social Anxiety Scale score \> 49).
Intervention (if applicable): Breathwork-assisted therapy 1 or breathwork-assisted therapy 2.
Main study parameters/endpoints: Primary outcomes will be self-reported levels of social anxiety. Performance and physiological response in a social interaction task will be used as a secondary measure.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Participants will be invited to the lab twice for the administration of behavioral tasks and two more times to participate to the breathwork sessions. Each visit will last about 2 hours. The treatment will run online and includes activities for a total 6.5h. Finally, we estimate a cumulative 1 hour to fill in all questionnaires. The total maximum load per participant is therefore 11.5 hours. Breathwork can produce an increased state of physiological arousal accompanied by elevations in heart rate and blood pressure that are considered safe in appropriately screened individuals. It also produces altered states of consciousness that may, in some cases, be characterized by transient anxiety. Participants may also experience discomfort during the social interaction task. In case the treatment yields the expected results, a potential benefit may be the reduction of social anxiety.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
baseline (t0), before each preparation session, after each preparation session (post-p1 and post-p2), before each breathwork session, after each breathwork session (post-bw1 and post-bw2), before each integration session, after each integration session (post-int1 and post-int2), 1 week after the last integration session (t1) and 1 month after last integration session (t2).
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathwork-assisted Therapy 1
The investigational treatment will include two preparation sessions, two breathwork sessions, and two integration sessions.
Breathwork-Assisted Therapy 1
The investigational treatment will include two preparation sessions, two breathwork sessions, and two integration sessions.
Breathwork-Assisted Therapy 2
The control treatment will include two preparation sessions, two breathwork sessions, and two integration sessions.
Breathwork-Assisted Therapy 2
The comparator treatment will include two preparation sessions, two breathwork sessions, and two integration sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathwork-Assisted Therapy 1
The investigational treatment will include two preparation sessions, two breathwork sessions, and two integration sessions.
Breathwork-Assisted Therapy 2
The comparator treatment will include two preparation sessions, two breathwork sessions, and two integration sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 65
* LSAS score ≥50
* Written informed consent
Exclusion Criteria
* History or presence of psychotic or bipolar disorders or first-degree relatives suffering from this
* History of respiratory or cardiovascular/heart problems or disease, cerebral aneurysm
* History of fainting or syncope, epilepsy or seizures
* History of panic disorder or panic attacks,
* Having had adverse reactions with prior breathwork sessions (i.e., fainting),
* Pregnancy, thinking one might be pregnant, trying to get pregnant, or breastfeeding
* Any problems affecting the ability to pace breathing (i.e., active/chronic respiratory infection including blocked nose/cough/cold/fever, etc.), breathlessness, abnormally slow breathing (bradypnea), or abnormally fast breathing (tachypnoea), any other physical/mental health conditions or current life events impairing the ability to engage in activities involving breath control
* Taking any regular medication other than the contraceptive pill, including medications to reduce blood pressure (i.e., Ramipril or other ACE-inhibitors) and beta-blockers (i.e., Propranolol).
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kim PC Kuypers, PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL87496.068.24
Identifier Type: REGISTRY
Identifier Source: secondary_id
P154
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.